Recent regulations in both Washington state and Oregon now allow out of state investors to fund and/or compete with local cannabis businesses.

Oregon and Washington recreational cannabis businesses will soon face greater pressure from outside competition as new regulations now allow out-of-state investors to fund and compete with local cannabis businesses. 

This new legislation lifts residency requirements enabling once banned out-of-state investors to participate-in and fund Oregon and Washington cannabis operations.

Meghan Walstatter owner of Pure Green Dispensary in Portland, Oregon said she used to favor residency requirements, but now she welcomes outside influence. 

Denver’s Cannabis Odor Ordinance leaves industry scrambling for solutions: Will other legal marijuana markets follow suit?

As Denver City Council passes an odor-control ordinance for commercial marijuana grow facilities and other businesses that release odors in the Mile High City, urban-gro, the product solutions expert for the commercial Cannabis cultivator, offers up a cutting-edge solution: FOGCO odor control system.

Nasdaq officials have told MassRoots, a sort of “Facebook for pot,” that it can't join the exchange.

The Denver-based social network has 775,000 users from the 24 states where marijuana is legal medicinally (including those states where it's also legal recreationally), who use the platform to find like-minded people in their area, learn about nearby dispensaries, and follow pot legalization news. MassRoots has said it meets the criteria for listing on Nasdaq—it has a $40 million market capitalization value and “well over 300 shareholders” through over-the-counter markets, according to CNN Money.

It is presently legitimate to purchase, possess, and devour pot for recreational purposes in large portions of the states. In this article, we dig deep into the business to disclose who’s getting rich from it and whether there’s an open door for different investors to get in on the action. And, we have come to the conclusion that yes! It is possible togenerate money legally with Cannabis.

The Cannabis Business is turning out to be a tropical storm in the nation. As per the ArcView Group, the legal cannabis industry developed by just about 75% in its first year and is required to keep on growing as more states push for marijuana change.

The union, which represents truck drivers and warehouse workers, has joined with law enforcement groups in funding opposition to a proposed ballot initiative in November.

The California branch of the 1.4-million member Teamsters union says it is opposed to a proposed ballot initiative on legalizing recreational marijuana use, and has joined police and prison guard associations in donating to a lobby group devoted to defeating the proposal.

The multipurpose plant, which has been used for centuries to make rope, textiles, foods, personal care products and more, became a controversial substance in 1937 due to the “Marihuana Tax Act,” which basically lumped hemp with marijuana and made it illegal to grow even though the former has no psychoactive properties. Hemp is listed as a federal Schedule 1 drug in the Controlled Substances Act.

With more states voting to legalise the product, a once criminal activity is fast entering the mainstream with financial institutions, advertisers, and blue-chip investment firms waking up to the wider possibilities of this flourishing industry.

Medical and recreational marijuana is now legal in 24 US states, with a further nine due to vote on legalisation over the course of this year.

Colorado was the first state to open up legal marijuana sales in 2014, and reported $1bn (€890m) in sales of the product last year.

More tellingly, the state’s tax take on marijuana is now double that of alcohol — a fact that has made every other state sit up and take notice of the potential revenue bonanza waiting to be tapped.

New evidence for the clinical efficacy of cannabis therapy is presented in the latest issue of the Journal of Basic and Clinical Physiology and Pharmacology (JBCPP), a De Gruyter publication. The authors have studied cannabis therapy for many years at international research centers, examining its effects, potential applications, and risks.

President Barack Obama still refuses to act on the issue of marijuana legalization, and reform advocates are getting tired of waiting.

Rep. Steve Cohen, a Democratic congressman from Tennessee, has discussed the legal status of cannabis with the president several times, asking Obama if he would consider at least rescheduling marijuana on the list of controlled substances so it can be researched further and treated as a less dangerous drug. But the president has maintained the same stance on changing drug policy during his whole presidency: Defer to Congress.

CAPE TOWN, SOUTH AFRICA--(Marketwired - May 23, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces arrival of a Cannabis Science delegation beginning in Cape Town, South Africa to launch a historic Africa Healthcare initiative led by President & CEO, Co-Founder Raymond C. Dabney.

Mr. Dabney is accompanied by Dr. Allen A. Herman, the Chief Medical Officer (CMO) of CBIS, Mr. Melvin P. Foote, President and Executive Director of Constituency for Africa (CFA), and Dr. Julius Garvey, surgeon and noted advocate for African healthcare and a member of the Scientific Advisory Board (SAB) of CBIS.